Home › Compare › GBLX vs ORCC

GBLX vs ORCC: Dividend Comparison 2026

GBLX yields 666666.67% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBLX wins by $3843184858461165056.00M in total portfolio value
10 years
GBLX
GBLX
● Live price
666666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3843184858461165056.00M
Annual income
$2,951,404,776,098,759,000,000,000.00
Full GBLX calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — GBLX vs ORCC

📍 GBLX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGBLXORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GBLX + ORCC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
GBLX pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GBLX
Annual income on $10K today (after 15% tax)
$56,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$2,508,694,059,683,945,000,000,000.00/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, GBLX beats the other by $2,508,694,059,683,945,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GBLX + ORCC for your $10,000?

GBLX: 50%ORCC: 50%
100% ORCC50/50100% GBLX
Portfolio after 10yr
$1921592429230582528.00M
Annual income
$1,475,702,388,049,379,400,000,000.00/yr
Blended yield
76.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

GBLX
No analyst data
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GBLX buys
0
ORCC buys
0
No recent congressional trades found for GBLX or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGBLXORCC
Forward yield666666.67% ✓9.79%
Annual dividend / share$2.00 ✓$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%-50%
Portfolio after 10y$3843184858461165056.00M ✓$21.4K
Annual income after 10y$2,951,404,776,098,759,000,000,000.00 ✓$1.04
Total dividends collected$3777696863071325696.00M ✓$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: GBLX vs ORCC ($10,000, DRIP)

YearGBLX PortfolioGBLX Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$33,344,033$33,333,333.33$11,190$489.61+$33.33M → GBLX
2$51,973,424,741$51,937,746,625.13$12,229$256.01+$51973.41M → GBLX
3$37,885,279,905,810$37,829,668,341,337.28$13,216$130.74+$37885279.89M → GBLX
4$12,926,234,563,052,674$12,885,697,313,553,460.00$14,207$66.02+$12926234563.04M → GBLX
5$2,068,281,583,056,657,700$2,054,450,512,074,191,400.00$15,234$33.17+$2068281583056.64M → GBLX
6$155,823,080,460,537,230,000$153,610,019,166,666,620,000.00$16,317$16.62+$155823080460537.22M → GBLX
7$5,574,621,214,635,156,000,000$5,407,890,518,542,381,000,000.00$17,468$8.32+$5574621214635156.00M → GBLX
8$96,370,936,431,909,830,000,000$90,406,091,732,250,210,000,000.00$18,695$4.16+$96370936431909824.00M → GBLX
9$833,439,329,310,660,000,000,000$730,322,427,328,516,400,000,000.00$20,006$2.08+$833439329310659968.00M → GBLX
10$3,843,184,858,461,165,000,000,000$2,951,404,776,098,759,000,000,000.00$21,407$1.04+$3843184858461165056.00M → GBLX

GBLX vs ORCC: Complete Analysis 2026

GBLX — Stock

GB Sciences, Inc. engages in the research and development of plant-based medicines in North America and Europe. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.

Full GBLX Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this GBLX vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GBLX vs SCHDGBLX vs JEPIGBLX vs OGBLX vs KOGBLX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.